Log In
Print
BCIQ
Print
Print this Print this
 

melphalan intraocular injection (IBI-80090)

  Manage Alerts
Collapse Summary General Information
Company Icon Bioscience Inc.
DescriptionIntraocular injection of melphalan using Icon's Verisome drug delivery technology
Molecular Target DNA
Mechanism of ActionAlkylating agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationRetinoblastoma
Indication DetailsTreat retinoblastoma
Regulatory Designation

U.S. - Orphan Drug (Treat retinoblastoma)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today